Teaching Investors How To Turn Pennies Into Dollars TM

Advertising    Contact Us
Welcome, Guest Login / Sign-Up
Navigation menu

Featured Link


Add Us to favorites

Click Here Now!
or hit CRL+D


Search Web Site


11:35 AM EST - : The Score: announced the financial results for the three months ended May 31, in accordance with International Financial Reporting Standards. Revenue was $2.0 million compared to $1.4 million for the same period the previous year, an increase of 44%. EBITDA loss was $2.1 million.

The Score (SCR:CA) is trading down $0.01 at $0.34.

11:33 AM EST - : Komet Resources: announced that it has obtained the final approval of the TSX Venture Exchange for the acquisition of the Guiro gold mine announced last spring.

Komet Resources Inc. (KMT:CA) is trading up $0.01 at $0.465.


4:25 PM EST - : Legend Power Systems announced the completion of its first Energy Saving Performance Agreement with the Toronto Atmospheric Fund and FINN Projects. Legend successfully installed six energy-saving Harmonizers, which save energy by regulating voltage, in facilities owned by a single company in the Greater Toronto Area.

Legend Power Systems Inc. (LPS:CA) closed up $0.03 at $0.51.

4:23 PM EST - : Canada Strategic Metals: and Matamec Explorations Inc. reported the results from two holes, drilled in March and April, during the latest exploration program on the Sakami gold property. The new results confirm the extension of the Zone 25 gold mineralization envelope to the west, to the northwest and at depth.

Canada Strategic Metals Inc. (CJC:CA) closed up $0.005 at $0.09.
Matamec Explorations Inc. (MAT:CA) closed up $0.005 at $0.08.

11:29 AM EST - : African Gold Group: announced the completion of drilling for the 2014 field season at Kobada, Mali. This body of work has resulted in the successful collection of over 2.4 tonnes of lateritic and saprolitic material that is representative of the Kobada ore types.

African Gold Group, Inc. (AGG:CA) is trading up $0.01 at $0.13.

11:27 AM EST - : Sirona Biochem Corp.: announced that Wanbang Biopharmaceuticals has completed two pre-clinical efficacy studies of its SGLT2 inhibitor SBM-TFC-039. The studies independently confirm that SBM-TFC-039 increased Urinary Glucose Excretion and improved Oral Glucose Tolerance in normal SD rats. The results were consistent with those previously completed by Sirona Biochem.

Sirona Biochem Corp. (SBM:CA) is trading up $0.01 at $0.11.

Copyright © AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.



AllPennyStocks.com © 1999 - 2014. AllPennyStocks.com is a web publishing venture produced by AllPennyStocks.com Media, Inc.